Thorne HealthTech Inc
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $10.13
- Today's High:
- $10.18
- Open Price:
- $10.13
- 52W Low:
- $3.41
- 52W High:
- $10.19
- Prev. Close:
- $10.14
- Volume:
- 116377
Company Statistics
- Market Cap.:
- $0
- Book Value:
- Revenue TTM:
- $0
- Operating Margin TTM:
- 0%
- Gross Profit TTM:
- $0
- Profit Margin:
- 0%
- Return on Assets TTM:
- 0%
- Return on Equity TTM:
- 0%
Company Profile
Thorne HealthTech Inc had its IPO on 2021-09-23 under the ticker symbol THRN.
The company operates in the Consumer Defensive sector and Packaged Foods industry. Thorne HealthTech Inc has a staff strength of 544 employees.
Stock update
Shares of Thorne HealthTech Inc opened at $10.13 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $10.13 - $10.18, and closed at $10.14.
This is a 0% increase from the previous day's closing price.
A total volume of 116,377 shares were traded at the close of the day’s session.
In the last one week, shares of Thorne HealthTech Inc have slipped by -0.3%.
Thorne HealthTech Inc's Key Ratios
Thorne HealthTech Inc has a market cap of $0, indicating a price to book ratio of 0 and a price to sales ratio of 0.
In the last 12-months Thorne HealthTech Inc’s revenue was $0 with a gross profit of $0 and an EBITDA of $0. The EBITDA ratio measures Thorne HealthTech Inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Thorne HealthTech Inc’s operating margin was 0% while its return on assets stood at 0% with a return of equity of 0%.
In Q0.33333333333333, Thorne HealthTech Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.
Thorne HealthTech Inc’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 0
- PEG
Its diluted EPS in the last 12-months stands at $0 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Thorne HealthTech Inc’s profitability.
Thorne HealthTech Inc stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of 0. Its price to sales ratio in the trailing 12-months stood at 0.
Thorne HealthTech Inc stock pays annual dividends of $ per share, indicating a yield of None and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $282.53 million
- Total Liabilities
- $56.25 million
- Operating Cash Flow
- $0
- Capital Expenditure
- $8.06 million
- Dividend Payout Ratio
- 0%
Thorne HealthTech Inc ended 2024 with $282.53 million in total assets and $0 in total liabilities. Its intangible assets were valued at $282.53 million while shareholder equity stood at $153.84 million.
Thorne HealthTech Inc ended 2024 with $0 in deferred long-term liabilities, $56.25 million in other current liabilities, 543714.00 in common stock, $-112296636.00 in retained earnings and $20.04 million in goodwill. Its cash balance stood at $17.09 million and cash and short-term investments were $17.09 million. The company’s total short-term debt was $5,115,436 while long-term debt stood at $24.11 million.
Thorne HealthTech Inc’s total current assets stands at $135.47 million while long-term investments were $2.38 million and short-term investments were $0. Its net receivables were $25.57 million compared to accounts payable of $40.56 million and inventory worth $71.69 million.
In 2024, Thorne HealthTech Inc's operating cash flow was $0 while its capital expenditure stood at $8.06 million.
Comparatively, Thorne HealthTech Inc paid $0 in dividends in 2024.
Other key metrics
- Current Trading Price
- $10.14
- 52-Week High
- $10.19
- 52-Week Low
- $3.41
- Analyst Target Price
- $
Thorne HealthTech Inc stock is currently trading at $10.14 per share. It touched a 52-week high of $10.19 and a 52-week low of $10.19. Analysts tracking the stock have a 12-month average target price of $.
Its 50-day moving average was $6.95 and 200-day moving average was $5.07 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 0% of the company’s stock are held by insiders while 0% are held by institutions.
Frequently Asked Questions About Thorne HealthTech Inc
Similar Industry Stocks (Packaged Foods)
Most Active
Top Gainers
Top Losers
About
Thorne HealthTech, Inc., a science-driven wellness company, provides solutions and personalized approaches to health and wellness in the United States and internationally. It offers various health tests, such as sleep, stress, weight management, gut health, heavy metals, biological age, and other health tests that generate molecular portraits for its customers, as well as develops nutritional supplements and offers wellness education solutions. The company uses the Onegevity platform to map, integrate, and understand the biological features that describe the state of an individual’s health, as well as provide actionable insights and personalized data, products, and services that help individuals to take a proactive approach to enhance and maintain their health. It primarily serves healthcare professionals, professional athletes, and professional sports and Olympic teams. Thorne HealthTech, Inc. was founded in 1984 and is headquartered in New York, New York.